Back to results
US 2017/0290818 A1Published application
NOVEL COMPOUNDS ALPHA v BETA 6 INTEGRIN ANTAGONISTS
AssigneeGlaxoSmithKline Intellectual Property Development Limited
InventorsNiall Andrew ANDERSON, Matthew Howard James CAMPBELL-CRAWFORD, Ashley Paul HANCOCK, Seble LEMMA, Simon John Fawcett MACDONALD, John Martin PRITCHARD, Panayiotis Alexandrou PROCOPIOU, Stephen SWANSON
Life of this patent
Estimating the term…
Abstract
A compound according to formula (I) wherein R1 is hydrogen, cyclopropyl, or pyrazolyl, wherein said pyrazolyl is optionally substituted by one or two methyl groups; or a pharmaceutically acceptable salt thereof.
Claims21
1-24. (canceled)
A compound according to formula (I):
- wherein R1 is hydrogen, cyclopropyl, or pyrazolyl, wherein said pyrazolyl is optionally substituted by one or two methyl groups;
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.